Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
LFCR Lifecore Biomedical	$7.60 +5.3%	$7.57	$3.68 ▼ $8.85	$284.32M	0.65	215,739 shs	119,681 shs
MGEN Miragen Therapeutics	$18.02 -0.7%	$17.69	$4.66 ▼ $34.05	$70.42M	1.66	134,027 shs	668,819 shs
OPGN OpGen	$0.00	$3.07	$0.00 ▼ $0.00	$1K	-1.77	1,028 shs	156 shs
SKIN Beauty Health	$2.21 +6.8%	$1.88	$0.78 ▼ $2.56	$280.27M	1.2	855,353 shs	1.02 million shs

The Best High-Yield Dividend Stocks for 2025

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
LFCR Lifecore Biomedical	-0.28%	-2.70%	-2.96%	+7.44%	+26.44%
MGEN Miragen Therapeutics	+1.85%	-3.77%	+8.04%	+32.70%	+15.54%
OPGN OpGen	0.00%	0.00%	-100.00%	-100.00%	-100.00%
SKIN Beauty Health	-2.36%	-4.61%	+13.11%	+28.57%	+30.19%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
LFCR Lifecore Biomedical	0.8181 of 5 stars	1.3	0.0	0.0	0.0	1.9	4.2	0.6
MGEN Miragen Therapeutics	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
OPGN OpGen	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SKIN Beauty Health	1.0462 of 5 stars	2.0	0.0	0.0	0.0	2.8	3.3	0.0

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
LFCR Lifecore Biomedical	2.50	Moderate Buy	$8.00	5.74% Upside
MGEN Miragen Therapeutics	0.00	N/A	N/A	N/A
OPGN OpGen	0.00	N/A	N/A	N/A
SKIN Beauty Health	2.00	Hold	$2.63	18.51% Upside

Current Analyst Ratings Breakdown

Latest MGEN, OPGN, SKIN, and LFCR Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
8/1/2025	SKIN Beauty Health	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Hold ➝ Hold	$3.00 ➝ $4.00

(Data available from 8/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
LFCR Lifecore Biomedical	$128.87M	2.20	N/A	N/A	$0.04 per share	189.15
MGEN Miragen Therapeutics	$4.46M	15.79	N/A	N/A	$6.78 per share	2.66
OPGN OpGen	$2.67M	0.00	N/A	N/A	($11.55) per share	0.00
SKIN Beauty Health	$334.30M	0.84	$0.07 per share	33.53	$0.58 per share	3.82

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
LFCR Lifecore Biomedical	-$38.72M	-$1.31	N/A	N/A	N/A	-31.70%	-846.51%	-13.03%	10/3/2025 (Estimated)
MGEN Miragen Therapeutics	-$41.87M	-$20.09	N/A	N/A	N/A	-1,393.50%	-141.66%	-88.74%	N/A
OPGN OpGen	-$32.67M	N/A	0.00	∞	N/A	-1,140.36%	N/A	-287.58%	N/A
SKIN Beauty Health	-$29.10M	-$0.28	N/A	N/A	N/A	-6.13%	-32.82%	-2.96%	N/A

Latest MGEN, OPGN, SKIN, and LFCR Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/25/2025	Q4 2025	LFCR Lifecore Biomedical	-$0.09	N/A	N/A	N/A	$35.36 million	N/A
8/7/2025	Q4 2025	LFCR Lifecore Biomedical	-$0.09	-$0.10	-$0.01	-$0.06	$35.36 million	$36.44 million
8/7/2025	Q2 2025	SKIN Beauty Health	-$0.06	$0.03	+$0.09	$0.03	$74.67 million	$78.20 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
LFCR Lifecore Biomedical	N/A	N/A	N/A	N/A	N/A
MGEN Miragen Therapeutics	N/A	N/A	N/A	N/A	N/A
OPGN OpGen	N/A	N/A	N/A	N/A	N/A
SKIN Beauty Health	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
LFCR Lifecore Biomedical	113.76	2.84	1.77
MGEN Miragen Therapeutics	0.20	4.23	4.23
OPGN OpGen	N/A	5.45	5.45
SKIN Beauty Health	4.91	5.15	4.15

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
LFCR Lifecore Biomedical	83.36%
MGEN Miragen Therapeutics	N/A
OPGN OpGen	2.68%
SKIN Beauty Health	93.26%

Insider Ownership

Company	Insider Ownership
LFCR Lifecore Biomedical	32.20%
MGEN Miragen Therapeutics	1.10%
OPGN OpGen	43.80%
SKIN Beauty Health	41.00%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
LFCR Lifecore Biomedical	690	37.41 million	25.36 million	Optionable
MGEN Miragen Therapeutics	45	3.91 million	N/A	Not Optionable
OPGN OpGen	100	10.07 million	4.70 million	Not Optionable
SKIN Beauty Health	1,030	126.82 million	74.83 million	Optionable

MGEN, OPGN, SKIN, and LFCR Headlines

Recent News About These Companies

Lendava Skin: An Engineer-Founded Skin-Care Brand Aiming to Streamline Routines

3 hours ago | msn.com

I'm 52 and test skin care for a living — here are my top products of the month

3 hours ago | aol.comA

Why gentle effective skincare is changing beauty routines

August 22 at 10:11 AM | msn.com

The Beauty of Longevity: How L'Oréal Is Reframing Aging and Beauty in China

August 22 at 5:10 AM | tirto.idT

Home Bargains reduces ‘holy grail’ skin care to £1.49

August 21 at 5:43 AM | msn.com

5 Myths and Facts About Collagen: What Really Works for Your Skin and Health

August 21 at 5:43 AM | herzindagi.comH

Skin Care: If you want to get beautiful and glowing skin, then try these DIY hacks for uneven skintone..

August 21 at 5:43 AM | msn.com

Cheryl's comeback glow: The star tells WH the beauty rules she won’t break

August 20 at 7:41 PM | msn.com

10 Best Natural Oils for Healthy, Glowing Skin

August 20 at 7:41 PM | herzindagi.comH

How to Get Glass Skin Like a K-Beauty Expert

August 20 at 7:41 PM | msn.com

Victoria Beckham's facialist says your skincare is ageing you - and reveals the secret to glowing skin after 50

August 19 at 11:02 PM | msn.com

Can Drinking Coriander Seed Water Help Improve Skin Health? My Experience

August 19 at 11:02 PM | herzindagi.comH

Ancient beauty secrets find place in modern skincare

August 19 at 4:24 AM | thestatesman.comT

Ask the Expert: Taking Care of the Skin You're In: Establishing healthy skin care routines can start early

August 19 at 4:24 AM | postandcourier.comP

Nu You Med Spa Blends Beauty and Wellness for Total Transformation

August 19 at 4:24 AM | news4sanantonio.comN

Travel tips: 10 beauty and skincare hack you must know

August 18, 2025 | timesofindia.indiatimes.com

Your lipstick is secretly affecting your health; harmful ingredients you need to watch out for

August 18, 2025 | msn.com

A 47-Year-Old Beauty Influencer Told Me Her Exact Routine for Preventing Wrinkles and Getting Glowy Skin

August 18, 2025 | msn.com

Should you trust the trend? A doctor’s take on IV drips for skin

August 17, 2025 | indiatvnews.comI

Skin Care Tips- Do you want to make your skin glowing and spotless, know its home remedies

August 16, 2025 | msn.com

Beauty Health (NASDAQ:SKIN) Upgraded by Wall Street Zen to Buy Rating

August 10, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

MGEN, OPGN, SKIN, and LFCR Company Descriptions

Lifecore Biomedical NASDAQ:LFCR

$7.60 +0.38 (+5.26%)

Closing price 04:00 PM Eastern

Extended Trading

$7.60 0.00 (0.00%)

As of 05:11 PM Eastern

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. The company engages in the manufacturing of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.

Miragen Therapeutics NASDAQ:MGEN

Miragen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing proprietary RNA-targeted therapies with a specific focus on microRNAs and their role in diseases where there is a high-unmet medical need. Its four lead product candidates include cobomarsen, an inhibitor of miR-155 for treating various blood cancers, such as cutaneous T-cell lymphoma, adult T-cell lymphoma/leukemia, diffuse large B-cell lymphoma, and chronic lymphocytic leukemia; Remlarsen, a replacement for miR-29, a microRNA that is found at abnormally low levels in various pathological fibrotic conditions, including cutaneous and ocular fibrosis, which is in Phase II clinical trial; MRG-229, which is in preclinical trial for the treatment of idiopathic pulmonary fibrosis; and MRG- 110, an inhibitor of miR-92, a microRNA expressed in endothelial cells, which has completed two Phase I clinical trial for the treatment of heart failure, wound healing, and other ischemic disease in the United States and Japan. Miragen Therapeutics, Inc. was founded in 2006 and is based in Boulder, Colorado.

OpGen NASDAQ:OPGN

$0.0001 0.00 (0.00%)

As of 11:49 AM Eastern

OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits. The company's products also comprise ARES Technology Platform, including ARES reference database on antimicrobial resistance using next generation sequencing technology and artificial intelligence powered bioinformatics solutions for antibiotic response prediction; and Unyvero Platform, an automated sample-to-answer molecular diagnostics platform that integrates automated sample preparation, analysis, and identification of disease relevant pathogens and antibiotic resistance markers. It also utilizes molecular diagnostics and informatics to help combat infectious diseases. The company helps clinicians with information about life threatening infections to enhance patient outcomes, and to decrease the spread of infections caused by multidrug-resistant microorganisms. OpGen, Inc. has a collaboration with the New York State Department of Health and ILÚM Health Solutions, LLC to develop a research program to detect, track, and manage antimicrobial-resistant infections at healthcare institutions. The company was incorporated in 2001 and is headquartered in Rockville, Maryland.

Beauty Health NASDAQ:SKIN

$2.21 +0.14 (+6.76%)

Closing price 04:00 PM Eastern

Extended Trading

$2.21 0.00 (0.00%)

As of 05:19 PM Eastern

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time